Related Experiment Video
Updated: Feb 17, 2026

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
Targeting epigenome with dietary nutrients in cancer: Current advances and future challenges
Mohammad Imran Khan1, Suvasmita Rath1, Vaqar Mustafa Adhami1
1Department of Dermatology, University of Wisconsin, Madison, WI 53706, United States.
Abstract:
Tumorigenesis and epigenetic are closely linked with each other. Epigenetic changes are potential regulators of gene expression without involving any change in the DNA itself. More interestingly, epigenetic changes are reversible heritable changes which pass through generations. Many dietary bioactive ingredients regulate epigenetic control of cells and influence biochemical processes. Correlation between epigenetic regulation and cancer onset has been well established. Recent studies provide important information on the role of bioactive dietary components in cancer prevention and therapy. Several bioactive components are responsible for modification of the epigenome by affecting DNA methylation, histone modification, micro RNAs (miRNAs) and long non-coding RNAs (lncRNAs). This review summarizes recent advancements in this field and describes the role of many bioactive components in regulating human epigenome and how these modifications can be exploited for prevention and treatment of cancer.
Insights
Dietary bioactive compounds influence epigenetics, impacting gene expression and cancer development. These compounds offer potential for cancer prevention and therapy by modifying the epigenome through mechanisms like DNA methylation and histone modifications.
Area of Science:
- Epigenetics and Cancer Biology
- Nutritional Science
- Molecular Oncology
Background:
- Tumorigenesis is intricately linked with epigenetic alterations, which regulate gene expression without changing DNA sequence.
- Epigenetic modifications are heritable and reversible, influencing cellular processes and disease development.
- Dietary bioactive ingredients are increasingly recognized for their ability to modulate epigenetic mechanisms.
Purpose of the Study:
- To review recent advancements in understanding the role of dietary bioactive components in epigenetics.
- To explore how these components influence the human epigenome for cancer prevention and therapy.
- To highlight the mechanisms by which bioactive compounds modify epigenetic marks.
Main Methods:
- Literature review of recent studies on dietary bioactive components and epigenetics.
- Analysis of research on epigenetic modifications including DNA methylation, histone modification, and non-coding RNAs (miRNAs and lncRNAs).
- Synthesis of findings on the impact of bioactive compounds on cancer development and treatment.
Main Results:
- Dietary bioactive components can modify the epigenome by targeting DNA methylation and histone modifications.
- Specific bioactive compounds influence microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), key epigenetic regulators.
- Evidence supports the role of these dietary factors in both cancer prevention and therapeutic strategies.
Conclusions:
- Epigenetic regulation by dietary bioactive components presents promising avenues for cancer prevention.
- Modulating the epigenome with specific nutrients offers potential for novel cancer therapies.
- Further research into bioactive compounds can lead to targeted epigenetic interventions for cancer treatment.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Pharmacogenomics: Identification of New Drug Targets
Cancer Prevention
Some...

